Profil
Hans Christopher Toll currently works at Umecrine Cognition AB, as Chief Financial Officer from 2021 and KDventures AB, as Chief Financial Officer from 2022.
Mr. Toll also formerly worked at AIK Fotboll AB, as Chief Financial Officer and QUIA PHARMA AB, as Chief Financial Officer.
Mr. Toll received his Masters Business Admin degree from Stockholm School of Economics.
Postes actifs de Hans Christopher Toll
| Sociétés | Poste | Début |
|---|---|---|
| KDVENTURES AB | Directeur Financier/CFO | 01/10/2022 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Directeur Financier/CFO | 01/01/2021 |
Anciens postes connus de Hans Christopher Toll
| Sociétés | Poste | Fin |
|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Directeur Financier/CFO | - |
| AIK FOTBOLL AB | Directeur Financier/CFO | - |
Formation de Hans Christopher Toll
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AIK Fotboll AB
AIK Fotboll AB Movies/EntertainmentConsumer Services Engages in the management of football teams and activities | Consumer Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Quiapeg Pharmaceuticals Holding AB
Quiapeg Pharmaceuticals Holding AB BiotechnologyHealth Technology Provides holdings in developing biopharmaceuticals for the treatment of metabolic disorders | Health Technology |
















